Characteristics
|
A convenient set consisting of five Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase (TK) inhibitors. The five inhibitors are: 5 mg of Canertinib (ABIN628985), 100 mg of Erlotinib, Hydrochloride (ABIN412173), 5 mg of Gefitinib (ABIN412176), 25 mg of Lapatinib, Ditosylate (ABIN412230), and 2 mg of PD 153035 Hydrochloride (ABIN412256).
|